New £9m hospital outpatient unit opens
The outpatient department at West Cornwall Hospital in Penzance cost £9m and was completed in early June.
The unit was designed to provide modern, accessible and technically advanced facilities.
Kate Shields, chief executive officer at NHS Cornwall and Isles of Scilly Integrated Care Board, said the department would help deliver treatment "as close to where people live as possible".
More news stories for Cornwall
Listen to the latest news for Cornwall
The new building has technology which enables staff to offer virtual care as well as face-to-face.
Steve Williamson, chief executive officer at the Royal Cornwall Hospitals NHS Trust, said the organisation had "worked tirelessly" with NHS partners and the local community to secure the investment for the unit.
Final year illustration students from Falmouth University were invited to submit works of art for one of their end-of-year modules, all of which are exhibited in the new building.
Work on the build began in February 2024.
Follow BBC Cornwall on X, Facebook and Instagram. Send your story ideas to spotlight@bbc.co.uk.
West Cornwall Hospital build hits milestone
Building work on new Cornish hospital unit starts
Royal Cornwall Hospitals NHS Trust
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Strange fingertip symptom could mean you have the UK's most deadly cancer
An unusual symptom in the fingertips could mean that you have one of the deadliest cancers in the UK. Finger clubbing means there are certain changes in the shape of your fingers and fingernails. It is also called digital clubbing or Hippocratic fingers. People with conditions such as heart or lung problems sometimes have these changes. Based on figures from Cancer Research UK, lung cancer accounts for roughly 34,800 deaths annually. This represents 21 per cent of all cancer-related deaths. What contributes to lung cancer's lethal nature is the fact that it rarely presents noticeable symptoms during its initial phases. Consequently, diagnosis may not be made until the illness has advanced significantly. The NHS states: "Lung cancer does not usually cause noticeable symptoms until it's spread through the lungs or into other parts of the body. This means the outlook for the condition is not as good as many other types of cancer." Hence, identifying any possible indicators of the condition at the earliest opportunity is crucial. One such indicator might appear at the fingertips. Cancer Research UK cautions that finger clubbing can be a symptom of lung cancer. This typically impacts the fingertips on both hands, progressing gradually over time. Recommended reading: People 'blown away' as giant sharks seen leaping out the water off UK coastlines Police to be handed stronger powers to stop disruptive E-scooters on streets New popular Paddy McGuinness show axed after just one series, per reports What is finger clubbing? Finger clubbing usually affects the top of the fingers on both hands. And can also affect toes. It seems to happen in stages: there is softening of the base of the nail (nail bed) and redness (erythema) of the skin around the nail the angle between the nail bed and the nail fold (the skin just below the cuticle) increases, which causes the nail to curve more than usual the nail and the skin around the nail look shiny, and the nail has ridges along the length of it the ends of the fingers look larger, giving the 'clubbed' appearance Finger clubbing generally takes years to develop. But it can happen quicker in certain conditions, such as a lung abscess.
Yahoo
5 hours ago
- Yahoo
Eli Lilly to hike U.K. Mounjaro Price 170% after Trump push
Eli Lilly is raising the price of the weight loss drug Mounjaro in the U.K., after President Donald Trump ramped up pressure on drugmakers to lower U.S. prices and raise them abroad. The price of the drug is expected to rise by up to 170% in September, increasing the cost of a monthly supply at the highest dose from £122 ($165) to £330 ($447). The company said it had agreed with the British government to raise prices while 'maintaining access' for patients covered by the U.K.'s National Health Service. Last month, Trump wrote to 17 of the world's biggest drugmakers , including Eli Lilly, Novo Nordisk, and Pfizer, demanding they slash prices for U.S. consumers as part of his 'most favored nation' policy. The scheme aims to bring down drug prices by tying charges in the U.S. to lower ones abroad. Eli Lilly said Thursday that it has 'intensified efforts to align prices across developed countries, especially in Europe'. 'We are continuing to work with certain governments and expect to make any necessary pricing adjustments by September 1, while providing continued access for patients,' it said. Prescription drug prices in the U.S. are often two to three times higher on average than those in other developed nations, according to the nonprofit Commonwealth Fund. The list price for a month's supply of Mounjaro in the U.S. is $1,079.77 before insurance. Eli Lilly added that it supports Trump's goal of keeping the U.S. the 'world's leading destination for biopharmaceutical research and manufacturing, and the objective of more fairly sharing the costs of breakthrough medical research across developed countries.' 'This rebalancing may be difficult, but it means the prices for medicines paid by governments and health systems need to increase in other developed markets like Europe in order to make them lower in the US,' it said. Trump wrote in July that he would 'deploy every tool in our arsenal to protect American families from continued abusive drug pricing practices' if companies did not comply with his demands, saying other countries had been 'freeloading on U.S. innovation'. Meanwhile, the pharmaceutical industry is bracing for planned U.S. tariffs of medicines imported into the country. Eli Lilly said Thursday that it opposes the tariffs, saying they will raise costs and limit access to drugs. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Bloomberg
6 hours ago
- Bloomberg
Swedish Startup Mindler Agrees to Buy Ieso Digital Health UK
Swedish startup Mindler AB has acquired Ieso Digital Health UK for an undisclosed sum as it seeks to build out its footprint in the online therapy market. The acquisition will give Mindler access to existing contracts with the National Health Service in England and Scotland, according to emailed comments. The company says it's seeking to benefit from increased demand for mental health services in the UK at a time of relatively high vacancy rates for doctors in the NHS mental health services.
